Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
SYS-CON.TV
Cloud Expo & Virtualization 2009 East
PLATINUM SPONSORS:
IBM
Smarter Business Solutions Through Dynamic Infrastructure
IBM
Smarter Insights: How the CIO Becomes a Hero Again
Microsoft
Windows Azure
GOLD SPONSORS:
Appsense
Why VDI?
CA
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
ExactTarget
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun
Sun's Incubation Platform: Helping Startups Serve the Enterprise
POWER PANELS:
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
Professor Brian Cox Joins the Big Thinkers at The Innovation Debate 2012

CHERTSEY, England, November 20, 2012 /PRNewswire/ --

World experts focus on innovation in times of austerity and its economic impact

The Royal Society, 20th November 2012, 4pm

Watch FREE live stream at http://www.innovationdebate.com

Chaired by Professor Jim Al-Khalili, Professor of Physics, author and broadcaster, the panel includes:

Professor Paul Boyle, Chief Executive, Economic and Social Research Council & President of Science Europe

Europe

Tudor Brown, Co-founder and former President of world-leading technology company ARM

Professor Brian Cox, Broadcaster, Physicist and Royal Society Research Fellow

Dr Beau Lotto, Founder of the Lottolab, University College London

Professor Andrew Geim, Nobel Prize winning Physics in 2010 for his groundbreaking work on graphene

Professor Mariana Mazzucato, RM Phillips Professor of Science and Technology at the University of Sussex

Professor Paul Workman, Deputy Chief Executive and Head of Cancer Therapeutics, The Institute for Cancer Research London
Jeremy Webb, Editor-in-Chief, New Scientist

  • Discussing big themes: innovation in times of austerity and how we nurture scientific innovators
  • Generating ideas: how to ensure that innovation is really valued and invested in

How do we nurture innovation in times of austerity? Who funds it? Does a lack of money encourage inventiveness or does it stifle innovation as everyone plays it safe?   And what about the innovators of the future?  Are we doing enough to nurture and support talent?

In a tough economic climate, innovation cannot be sacrificed. It is the lifeblood of science, technology and the economy. There is an urgent need to focus on how best to promote and nurture innovation - today and in the future.

That is why The Innovation Debate 2012 - organised and funded by Astellas Pharma Europe Ltd., at the Royal Society, at 4pm on Tuesday 20th November 2012, is bringing  together influential and respected figures from the worlds of science, technology, medicine, engineering, education, government, industry and media to discuss how best to encourage and nurture scientific innovation.

Chaired by physicist, author and broadcaster Professor Jim Al-Khalili, and with panellists including Nobel prize- winning physicist Professor Sir Andre Geim, the co-founder and former president of technology company ARM Tudor Brown, broadcaster and physicist Professor Brian Cox,  and the Deputy Chief Executive and Head of Cancer Therapeutics at The Institute for Cancer Research London Professor Paul Workman, The Innovation Debate will examine how we can prevent today's economic and budgetary pressures from jeopardising  innovation for current and future generations.

The aim of The Innovation Debate is to air crucial issues, draw positive conclusions and to move the agenda forward.

Everyone - professionals in science and technology, students and the general public - will have the opportunity to engage with The Innovation Debate through online media which will take discussions far beyond the walls of the Royal Society.

"The Innovation Debate is a timely event," says Professor Jim Al-Khalili. "The world of science and technology needs to reclaim the very word 'innovation'. So how can we encourage innovation in today's age of austerity - and how do we ensure we have the innovators of the future? We need to consider how we can maximise the chances of producing innovative ideas from our scientists and technologists and how we should train the next generation of scientists and engineers.

"Like every other field of endeavour, scientific research is under pressure for funding - but what are the implications of, say, cutting funding for basic research if its economic or societal benefits are not immediately evident? And how might innovation suffer as a result? These are the kind of questions we will be discussing at The Innovation Debate."

Among the subjects for debate on 20th November are: 'How to innovate in a time of austerity?' and 'How best to nurture innovation?'

Join the Innovation Debate 2012

The Innovation Debate will encourage wider participation from the public and science community via the website. Everyone will have the opportunity to share their views on the critical challenges facing science and innovation raised by The Innovation Debate and to submit a question to the panel of experts. To watch the live webcast of the Debate from 4pm on 20th November 2012, register FREE today at http://www.innovationdebate.com

Join the debate now at http://www.innovationdebate.com  and follow us on Twitter @Innovatedebate #innovationdebate

About Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is the European headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation's focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants. The company employs approximately 4,300 staff across these regions. For more information about Astellas Pharma Europe, please visit http://www.astellas.eu.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Software AG helps organizations transform into Digital Enterprises, so they can differentiate from competitors and better engage customers, partners and employees. Using the Software AG Suite, companies can close the gap between business and IT to create digital systems of differ...
In this challenging environment, a combination of automated integration testing and test virtualization can enable test teams to improve software quality and keep up with the rate of change. This white paper helps address these needs by describing the benefits that can be gained ...
The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that...
The Internet of Things (IoT) promises to create new business models as significant as those that were inspired by the Internet and the smartphone 20 and 10 years ago. What business, social and practical implications will this phenomenon bring? That's the subject of "Monetizing th...
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021



SYS-CON Featured Whitepapers
ADS BY GOOGLE

Breaking Cloud Computing News

Alibaba Group (NYSE:BABA) announced that Taobao (China) Software Co., Ltd., a subsi...